Agios Pharmaceuticals, Inc. (AGIO) Revenue 2016–2025
Agios Pharmaceuticals, Inc. (AGIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$54.0MFY2025 · since FY2016: $69.9M → $54.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.0M | +48.0% |
| FY2024 | $36.5M | +36.1% |
| FY2023 | $26.8M | +88.4% |
| FY2022 | $14.2M | — |
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $117.9M | +24.9% |
| FY2018 | $94.4M | +119.4% |
| FY2017 | $43.0M | -38.5% |
| FY2016 | $69.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice